Clinical Trials Browser

Embolism, Neoplasms, Venous Thromboembolism

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

1,150 enrolled

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

996 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT07270263 2025-12-26

HEM-DOAC

Phase NA Recruiting

100 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

108 enrolled

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

330 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

30 enrolled

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

44 enrolled

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT05461807 2022-10-26

H2H-OSCAR-US

Completed

2,437 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Completed

97,765 enrolled

Classical hematology

Venous Thromboembolism

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Phase 2 Terminated

60 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02366871 2020-03-31

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Phase 2 Completed

400 enrolled 16 charts

Classical hematology

Venous Thromboembolism

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02048865 2018-11-20

AVERT

Phase 2 Completed

575 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT03083782 2017-10-11

ACT

Phase 1 Completed

12 enrolled

Classical hematology

Venous Thromboembolism

Clinical Trials

VICTORIE

ASTER

DOAC

HEM-DOAC

MYELAXAT

CARAVAGGIO

STREAM-Line

Apixaban in Thrombocytopenia

AIRPORT-MPN

CANVAS

H2H-OSCAR-US

PRACTISE

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

AVERT

ACT